Brief: Chiome Bioscience receives decision to grant TROP-2 antibody related patent in Europe

Chiome Bioscience

06/09/2017 08:32

Sept 6 (Reuters) - Chiome Bioscience Inc  4583.T   
     
     
    * Says it received a decision to grant patent for Anti-Human 
Trop-2 Antibody Having Antitumor Activity in Vivo,(application 
No. 11783675.9) in Europe, on Sept. 6   
     
    Source text in Japanese:https://goo.gl/WoYj1G 
    Further company coverage: 4583.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))